CIK 0001802768 · Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- (212) 883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,324,753
- in 4 filings, $12.3M under 10b5-1 plans
Net −$12,324,753. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-24 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −3,126 | $38.67 | $121K | 51,634 |
| 2025-11-24 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −624 | $37.96 | $24K | 51,010 |
| 2025-11-19 | Lloyd George W. EVP, Investments & CLO | Sale 10b5-1 | −47,798 | $38.28 | $1.8M | 10,712 |
| 2025-11-19 | Lloyd George W. EVP, Investments & CLO | Sale 10b5-1 | −4,628 | $39.01 | $181K | 6,084 |
| 2025-11-19 | Lloyd George W. EVP, Investments & CLO | Sale 10b5-1 | −47,401 | $38.28 | $1.8M | 4,599 |
| 2025-11-19 | Lloyd George W. EVP, Investments & CLO | Sale 10b5-1 | −4,599 | $39.01 | $179K | 0 |
| 2025-11-19 | Lloyd George W. EVP, Investments & CLO | Sale 10b5-1 | −25,530 | $38.28 | $977K | 2,470 |
| 2025-11-19 | Lloyd George W. EVP, Investments & CLO | Sale 10b5-1 | −2,470 | $39.01 | $96K | 0 |
| 2025-11-19 | Lloyd George W. EVP, Investments & CLO | Sale 10b5-1 | −2,770 | $38.29 | $106K | 230 |
| 2025-11-19 | Lloyd George W. EVP, Investments & CLO | Sale 10b5-1 | −230 | $39.03 | $9K | 0 |
| 2025-11-17 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −65,844 | $39.30 | $2.6M | 724,156 |
| 2025-11-17 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −3,750 | $39.30 | $147K | 54,760 |
| 2025-11-07 | Urist Marshall EVP, Research & Investments | Conversion | +160,000 | 206,667 | ||
| 2025-11-07 | Urist Marshall EVP, Research & Investments | Conversion · LP interests in RPI US Partners 2019, LP | −16,000 | 247,412 | ||
| 2025-11-05 | Urist Marshall EVP, Research & Investments | Grant or award | +4,626 | 43,882 | ||
| 2025-11-05 | Lloyd George W. EVP, Investments & CLO | Grant or award | +6,168 | 58,510 | ||
| 2025-11-05 | Coyne Terrance P. EVP & CFO | Grant or award | +6,168 | 58,510 | ||
| 2025-11-05 | Hite Christopher EVP & Vice Chairman | Grant or award | +6,168 | 658,510 | ||
| 2025-11-05 | Legorreta Pablo G. CEO, Chairman of the Board | Grant or award | +36,559 | 940,955 | ||
| 2025-09-30 | Bassler Bonnie L Director | Grant or award | +1,047 | $35.79 | $37K | 72,165 |
Page 6 of 8 · 159 trades